IndraLab

Statements


USP4-C311A leads to the deubiquitination of p38. 1 / 1
| 1

reach
"USP4 (C311A) mutation did not inhibit the TAK1 polyubiquitination, and phosphorylation of TAK1, = JNK1/2, and p38 in angiotensin treated myocytes."